215 related articles for article (PubMed ID: 30463221)
1. Structure⁻Activity Relationship Study of Newly Synthesized Iridium-III Complexes as Potential Series for Treating Thrombotic Diseases.
Yang CH; Hsia CW; Jayakumar T; Sheu JR; Hsia CH; Khamrang T; Chen YJ; Manubolu M; Chang Y
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463221
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
3. Novel iridium (III)‑derived organometallic compound for the inhibition of human platelet activation.
Shyu KG; Velusamy M; Hsia CW; Yang CH; Hsia CH; Chou DS; Jayakumar T; Sheu JR; Li JY
Int J Mol Med; 2018 May; 41(5):2589-2600. PubMed ID: 29436605
[TBL] [Abstract][Full Text] [Related]
4. New Therapeutic Agent against Arterial Thrombosis: An Iridium(III)-Derived Organometallic Compound.
Hsia CW; Velusamy M; Tsao JT; Hsia CH; Chou DS; Jayakumar T; Lee LW; Li JY; Sheu JR
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29206177
[TBL] [Abstract][Full Text] [Related]
5. Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate.
Hsia CW; Wu MP; Velusamy M; Hsia CH; Chou DS; Tsai CL; Hsu CY; Jayakumar T; Chung CL; Sheu JR
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104547
[TBL] [Abstract][Full Text] [Related]
6. Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets.
Hsia CH; Jayakumar T; Sheu JR; Tsao SY; Velusamy M; Hsia CW; Chou DS; Chang CC; Chung CL; Khamrang T; Lin KC
Molecules; 2018 Feb; 23(2):. PubMed ID: 29470443
[TBL] [Abstract][Full Text] [Related]
7. Levobupivacaine differentially suppresses platelet aggregation by modulating calcium release in a dose-dependent manner.
Liou JT; Mao CC; Liu FC; Lin HT; Hung LM; Liao CH; Day YJ
Acta Anaesthesiol Taiwan; 2012 Sep; 50(3):112-21. PubMed ID: 23026170
[TBL] [Abstract][Full Text] [Related]
8. Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways.
Lien LM; Lin KH; Huang LT; Tseng MF; Chiu HC; Chen RJ; Lu WJ
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704925
[TBL] [Abstract][Full Text] [Related]
9. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
10. Esculetin, a Coumarin Derivative, Prevents Thrombosis: Inhibitory Signaling on PLCγ2-PKC-AKT Activation in Human Platelets.
Hsia CW; Lin KC; Lee TY; Hsia CH; Chou DS; Jayakumar T; Velusamy M; Chang CC; Sheu JR
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163690
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Human Platelet Activation via Integrin α
Hsia CW; Tsai CL; Sheu JR; Lu WJ; Hsia CH; Velusamy M; Jayakumar T; Li JY
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717348
[TBL] [Abstract][Full Text] [Related]
13. Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice.
Chung CL; Chen JH; Huang WC; Sheu JR; Hsia CW; Jayakumar T; Hsia CH; Chiou KR; Hou SM
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232674
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet action of indirubin-3'-monoxime through suppression of glycoprotein VI-mediated signal transduction: a possible role for ERK signaling in platelets.
Lee JJ; Han JH; Jung SH; Lee SG; Kim IS; Cuong NM; Huong TT; Khanh PN; Kim YH; Yun YP; Ma JY; Myung CS
Vascul Pharmacol; 2014 Dec; 63(3):182-92. PubMed ID: 25451564
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological actions of neferine in the modulation of human platelet function.
Yang RP; Zhou YJ; Song W; Yin Z; He AD; Ming ZY
Eur J Pharmacol; 2019 Nov; 862():172626. PubMed ID: 31445013
[TBL] [Abstract][Full Text] [Related]
16. A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies.
Hsia CH; Velusamy M; Sheu JR; Khamrang T; Jayakumar T; Lu WJ; Lin KH; Chang CC
Sci Rep; 2017 Aug; 7(1):9556. PubMed ID: 28842683
[TBL] [Abstract][Full Text] [Related]
17. A novel naphthalimide derivative reduces platelet activation and thrombus formation via suppressing GPVI.
Shih TL; Lin KH; Chen RJ; Chen TY; Kao WT; Liu JW; Wang HH; Peng HY; Sun YY; Lu WJ
J Cell Mol Med; 2021 Oct; 25(19):9434-9446. PubMed ID: 34448532
[TBL] [Abstract][Full Text] [Related]
18. A novel antithrombotic effect of sulforaphane via activation of platelet adenylate cyclase: ex vivo and in vivo studies.
Jayakumar T; Chen WF; Lu WJ; Chou DS; Hsiao G; Hsu CY; Sheu JR; Hsieh CY
J Nutr Biochem; 2013 Jun; 24(6):1086-95. PubMed ID: 23246160
[TBL] [Abstract][Full Text] [Related]
19. Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism.
Yen TL; Wu MP; Chung CL; Yang WB; Jayakumar T; Geraldine P; Chou CM; Chang CY; Lu WJ; Sheu JR
J Biomed Sci; 2016 Feb; 23():26. PubMed ID: 26887315
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Glycoprotein VI Clustering by Collagen as a Mechanism of Inhibiting Collagen-Induced Platelet Responses: The Example of Losartan.
Jiang P; Loyau S; Tchitchinadze M; Ropers J; Jondeau G; Jandrot-Perrus M
PLoS One; 2015; 10(6):e0128744. PubMed ID: 26052700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
